• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Happify Health Raises $9M To Expand Evidence-based Emotional Health Platform for Employers & Health Plans

by Fred Pennic 08/15/2017 Leave a Comment

Happify Health Raises $9M To Expand Evidence-based Emotional Health Platform for Employers & Health Plans

Happify Health, a New York City-based provider of evidence-based emotional health software solutions for employers and health plans has raised $9 million in funding led by  TT Capital Partners (“TTCP”) with participation from existing investors. The company plans to use the funding to increase infrastructure support and expand its digital platform that provides clinically tested, highly personalized behavior change interventions for use across the emotional health continuum. 

Founded in 2012, Happify works with individuals, health plans, employers and care delivery systems, providing solutions that address areas ranging from resilience and stress to depression, anxiety and social isolation that often accompany chronic illness. Happify Health’s digital intervention platform provides more than 60 programs and over 2,500 activities that use evidence-based science, unparalleled engagement strategies, software and gamification to improve access, deliver emotional health outcomes and significantly reduce costs. Happify is based on decades of scientific research on interventions that foster well-being and resilience in individuals, drawing from the fields of positive psychology, mindfulness, and cognitive behavioral therapy.

The company recently landed a partnership with Humana to explore how to best help members reduce depression and anxiety through better integrated, digitally-delivered behavioral health solutions. Humana’s program will be integrated into Humana care management, which will use Happify Health tools to screen chronic heart condition patients. The patients who qualify who have signs of depression will then be enrolled into the program.

“After such rapid growth with enterprise clients over the past year, Happify Health is thrilled to expand our business with such a trusted investor with strong ties to the healthcare industry,” said Tomer Ben-Kiki, co-founder and CEO at Happify. “Happify Health is pioneering a new paradigm that combines evidence-based, low-cost and effective emotional health interventions with an innovative user experience and exceptional engagement levels. This funding will allow us to expedite the adoption of innovative delivery models by the healthcare industry.”

Tagged With: behavior, Evidence-based Emotional Health, Happify Health

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |